Volatile biomarkers in the breath of women with breast cancer

Journal of Breath Research

Volumn 4, Issue 2, 2010, Pages

  Phillips, Michael ^a,b   Cataneo, Renee N ^a   Saunders, Christobel ^c   Hope, Peter ^c   Schmitt, Peter ^d   Wai, James ^a  

^a MENSSANA RESEARCH INC   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d Schmitt and Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYTOCHROME P450; VOLATILE ORGANIC COMPOUND; TUMOR MARKER;

ADULT; ALGORITHM; AMBIENT AIR; AREA UNDER THE CURVE; ARTICLE; BREAST CANCER; BREATH ANALYSIS; BREATHING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME INDUCTION; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LUNG ALVEOLUS; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; MONTE CARLO METHOD; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; TIME; TRAINING; TUMOR BIOPSY; VALIDATION STUDY; BREAST TUMOR; CASE CONTROL STUDY; COMPARATIVE STUDY; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; VOLATILIZATION;

ADULT; BREAST NEOPLASMS; BREATH TESTS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; VOLATILIZATION;

EID: 77952948701     PISSN: 17527155     EISSN: 17527163     Source Type: Journal    
DOI: 10.1088/1752-7155/4/2/026003     Document Type: Article

References (45)

1. Lippman M E 2005 Breast cancer Harrison's Principles of Internal Medicine 16th edn (New York: McGraw Hill) pp 516-23 chapter 76
2. Parkin D M 2004 International variation Oncogene 23 6329-40
3. SEER National Cancer Institute Statistics Review 1975-2005 Table I-1 (Breast cancer) National Institutes of Health
4. Feig SA 2005 Screening mammography controversies: resolved, partly resolved, and unresolved Breast J. 11 ((Suppl 1)) S3-6
5. Chu D and Lu J 2008 Novel therapies in breast cancer: what is new from ASCO 2008 J. Hematol. Oncol. 1 16
6. Oestreicher N, Lehman C D, Seger D J, Buist D S and White E 2005 The incremental contribution of clinical breast examination to invasive cancer detection in a mammography screening program AJR Am. J. Roentgenol 184 428-32
7. Baines C J 2005 Are there downsides to mammography screening? Breast J. 11 ((Suppl 1)) S7-10
8. Kasapovic J, Pejic S, Todorovic A, Stojiljkovic V and Pajovic S B 2008 Antioxidant status and lipid peroxidation in the blood of breast cancer patients of different ages Cell Biochem. Funct. 26 723-30
9. Mense S M, et al. 2008 Estrogen-induced breast cancer: alterations in breast morphology and oxidative stress as a function of estrogen exposure Toxicol. Appl. Pharmacol. 232 78-85
10. Hietanen E, et al. 1994 Diet and oxidative stress in breast, colon and prostate cancer patients: a case-control study Eur. J. Clin. Nutr. 48 575-86
11. Kneepkens C M, Ferreira C, Lepage G and Roy C C 1992 The hydrocarbon breath test in the study of lipid peroxidation: principles and practice Clin. Invest. Med. 15 163-86
12. Phillips M, et al. 2003 Volatile markers of breast cancer in the breath Breast J. 9 184-91
13. Phillips M, et al. 2006 Prediction of breast cancer using volatile biomarkers in the breath Breast Cancer Res. Treat. 99 19-21
14. Phillips M, et al. 2007 Prediction of lung cancer using volatile biomarkers in breath Cancer Biomark 3 95-109
15. Phillips M, et al. 2007 Volatile biomarkers of pulmonary tuberculosis in the breath Tuberculosis (Edinb) 87 44-52 (Pubitemid 44960164)
16. Phillips M, et al. 2004 Heart allograft rejection: detection with breath alkanes in low levels (the HARDBALL study) J. Heart Lung Transplant. 23 701-8
17. Balleyguier C, Ayadi S, Van Nguyen K, Vanel D, Dromain C and Sigal R 2007 BIRADS classification in mammography Eur. J. Radiol. 61 192-4
18. Phillips M 1997 Method for the collection and assay of volatile organic compounds in breath Anal. Biochem. 247 272-8
19. Phillips M, Cataneo R N, Greenberg J, Gunawardena R, Naidu A and Rahbari-Oskoui F 2000 Effect of age on the breath methylated alkane contour, a display of apparent new markers of oxidative stress J. Lab. Clin. Med. 136 243-9
20. Cook N R 2007 Use and misuse of the receiver operating characteristic curve in risk prediction Circulation 115 928-35
21. Phillips M, et al. 2008 Detection of lung cancer using weighted digital analysis of breath biomarkers Clin. Chim. Acta 393 (2) 76-84
22. Pisano E D, et al. 2005 Diagnostic performance of digital versus film mammography for breast-cancer screening N. Engl. J. Med. 353 1773-83
23. Metropolis N and Ulam S 1949 The Monte Carlo method J. Am. Stat. Assoc. 44 335-41
24. Ma S, Song X and Huang J 2006 Regularized binormal ROC method in disease classification using microarray data BMC Bioinformatics 7 253
25. Zou Y Y, Yang J and Zhu J 2006 A robust statistical procedure to discover expression biomarkers using microarray genomic expression data J. Zhejiang Univ. Sci. 7 603-7
26. Phillips M, et al. 2008 Detection of lung cancer using weighted digital analysis of breath biomarkers Clin. Chim. Acta 393 76-84
27. Subramanian A, Salhab M and Mokbel K 2008 Oestrogen producing enzymes and mammary carcinogenesis: a review Breast Cancer Res. Treat. 111 191-202
28. Russo J and Russo I H 2006 The role of estrogen in the initiation of breast cancer J. Steroid Biochem. Mol. Biol. 102 89-96
29. Richards J A, Petrel T A and Brueggemeier R W 2002 Signaling pathways regulating aromatase and cyclooxygenases in normal and malignant breast cells J. Steroid Biochem. Mol. Biol. 80 203-12
30. Chen S 1998 Aromatase and breast cancer Front Biosci. 3 d922-33
31. Arun B and Goss P 2004 The role of COX-2 inhibition in breast cancer treatment and prevention Semin. Oncol. 31 ((Suppl 7)) 22-9
32. Jongen V H, Hollema H, Van Der Zee A G and Heineman M J 2006 Aromatase in the context of breast and endometrial cancer. A review Minerva Endocrinol. 31 47-60
33. Hannemann F, Bichet A, Ewen K M and Bernhardt R 2007 Cytochrome P450 systems-biological variations of electron transport chains Biochim. Biophys. Acta 1770 330-44
34. Kneepkens C M, Lepage G and Roy C C 1994 The potential of the hydrocarbon breath test as a measure of lipid peroxidation Free Radic. Biol. Med. 17 127-60
35. Ambrosone C B 2000 Oxidants and antioxidants in breast cancer Antioxid. Redox Signal. 2 903-17
36. Li D, Zhang W, Sahin A A and Hittelman W N 1999 DNA adducts in normal tissue adjacent to breast cancer: a review Cancer Detect. Prev. 23 454-62
37. Hietanen E, et al. 1994 Diet and oxidative stress in breast, colon and prostate cancer patients: a case-control study Eur. J. Clin. Nutr. 48 575-86
38. Concato J, Feinstein A R and Holford T R 1993 The risk of determining risk with multivariable models Ann. Int. Med. 118 201-10
39. Holson R R, Freshwater L, Maurissen J P, Moser V C and Phang W 2008 Statistical issues and techniques appropriate for developmental neurotoxicity testing: a report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints Neurotoxicol. Teratol. 30 326-48
40. Antoniewicz M R, Stephanopoulos G and Kelleher J K 2006 Evaluation of regression models in metabolic physiology: predicting fluxes from isotopic data without knowledge of the pathway Metabolomics 2 41-52
41. Phillips M, Herrera J, Krishnan S, Zain M, Greenberg J and Cataneo R N 1999 Variation in volatile organic compounds in the breath of normal humans J. Chromatogr. B Biomed. Sci. Appl. 729 75-88 (Pubitemid 29264111)
42. Stern N J, Kotula A W and Pierson M D 1979 Differentiation of selected Enterobacteriaceae by pyrolysis-gas-liquid chromatography Appl. Environ. Microbiol. 38 1098-102
43. Stern N J, Kotula A W and Pierson M D 1980 Virulence prediction of Yersinia enterocolitica by pyrolysis gas-liquid chromatography Appl. Environ. Microbiol. 40 646-51
44. Statheropoulos M, Agapiou A and Georgiadou A 2006 Analysis of expired air of fasting male monks at Mount Athos J. Chromatogr. 832 274-9
45. Wallace L 1996 Environmental exposure to benzene: an update Environ. Health Perspect. 104 ((Suppl 6)) 1129-36